Virtu Financial’s BioNexus Gene Lab BGLC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-2,737
Closed -$13K 1380
2024
Q2
$13K Sell
2,737
-1,967
-42% -$9.34K ﹤0.01% 1093
2024
Q1
$33K Buy
4,704
+2,089
+80% +$14.7K ﹤0.01% 1087
2023
Q4
$14K Sell
2,615
-3,354
-56% -$18K ﹤0.01% 1371
2023
Q3
$50K Buy
+5,969
New +$50K 0.01% 902